October 03, 2025

Older Women With High-Risk Breast Cancer: Addition of Adjuvant Chemotherapy to Hormone Therapy

In a French-Belgian phase III trial (ASTER 70s) reported in The Lancet, Brain et al examined the survival benefit of adding adjuvant chemotherapy to hormone therapy in women aged ≥ 70 years with estro...

The ASCO Post

October 03, 2025

Advanced or Metastatic Breast Cancer: FDA Approves Imlunestrant for ER-Positive, HER2-Negative, ESR1-Mutated Disease

The FDA approved the estrogen receptor antagonist for adults with estrogen receptor (ER)-positive, HER2-negative, estrogen receptor 1 (ESR1)-mutated advanced or metastatic disease with progression aft...

The ASCO Post

October 02, 2025

Can Older Breast Cancer Patients Tolerate Immunotherapy Plus Chemotherapy?

Using a newer combination of immunotherapy and lower doses of chemotherapy, USC Norris Comprehensive Cancer Center experts treated a 79-year-old woman with triple-negative breast cancer.

Keck Medicine of USC

September 30, 2025

Baptist Health Cancer Care Appoints Breast Surgical Oncologist Anastasia Tousimis, M.D., to Multiple Leadership Roles

https://baptisthealth.net/doctors/anastasia-tousimis/4857103

Baptist Health South Florida

September 18, 2025

Leading Societies Update Clinical Guideline on Postmastectomy Radiation Therapy

ASCO, ASTRO, and SSO have issued an updated guideline on postmastectomy radiation therapy (PMRT) for physicians treating patients with breast cancer. The recommendations outline when PMRT is appropria...

The ASCO Post

January 01, 0001

Overview of the AVADO and RIBBON-1 Clinical Trials

The evolving debate around bevacizumab's role in metastatic breast cancer reflects the complexities of targeted therapies and regulatory oversight.

JADPRO

January 01, 0001

Reevaluating Bevacizumab: The Role of VEGF Inhibitors in Metastatic Breast Cancer

The evolving landscape of metastatic breast cancer treatment illustrates both progress and caution, as evidenced by the FDA's reconsideration of bevacizumab.

JADPRO

March 10, 2023

Four Leading UPMC/Pitt Scientists Receive Funding for Research in Breast Cancer

UMPC Hillman Cancer Center researchers receive significant funding from the Breast Cancer Research Foundation to support investigations aiming to improve cancer screening and enhance HER2 therapy.

The ASCO Post

February 10, 2021

Severity of Patients’ Symptoms May Be Underrecognized During and After Breast Radiotherapy

Physicians may commonly underrecognize radiation-associated symptoms and their severity compared with self-reports of patients with breast cancer, according to a large study comparing patient-­reporte...

The ASCO Post